Clinimetrics properties of patient reported outcome measures to measure health-related quality of life in the BronchUK study

Judy M. Bradley*1; Katherine O’Neill*1; Kathryn Ferguson2; Adam T.
Hill*3; Michael R. Loebinger*4; Mary Carroll*5; Timothy Gatheral*6;
Anthony De Soyza*7; James D. Chalmers*8; Chris Johnson*9; John R.
Hurst*10; Jeremy Brown10; Andrew Bailey11; Joseph S. Elborn*1
1Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine,
Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, United
Kingdom; 2Belfast Health and Social Care Trust, Belfast, United Kingdom; 3Royal
Infirmary and University of Edinburgh, Edinburgh, United Kingdom; 4Royal
Brompton Hospital and Imperial College London, London, United Kingdom;
5University Hospital Southampton NHS Foundation Trust, Southampton,
United Kingdom; 6Department of Respiratory Medicine, University Hospitals
of Morecambe Bay NHS Foundation Trust, Morecambe Bay, United Kingdom;
7Institute of Cellular Medicine, Newcastle University, National Institute of Health
Research Biomedical Research Centre, Newcastle, United Kingdom; 8University
of Dundee, College of Medicine, Dundee, United Kingdom; 9Cambridge Centre
for Lung Infection, Papworth Hospital, Cambridge, United Kingdom; 10UCL
Respiratory, University College London, London, United Kingdom; 11Frontier
Science (Scotland) Ltd., Kincraig, United Kingdom
*On behalf of BRONCH-UK consortium